1Vickers A J, Elkin EB. Decision curve analysis:a novel method for evalu- ating prediction models. Med Decis Making ,2006,26:565-574.
2Pauker SG, Kassirer JP. The threshold approach to clinical decision mak- ing. N Engl J Med,1980,302:1109-1017.
3Baker SG, Kramer BS. Peirce, Youden, and Receiver Operating Charac- teristic Curves. The American Statistician, 2007,61 : 343-346.
4Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-spe- cific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. Jama, 1997,277 : 1445-1451.
5Makarov DV, Trock B J, Humplareys EB, et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology ,2007,69 : 1095-1101.
6Xiao WJ, Ye DW, Yao XD, et al. Comparison of accuracy among three generations of Parfin tables in a Chinese cohort. Can J Urol, 2011,18: 5619-5624.
7Vickers AJ, Jang K, Sargent D, et al. Systematic review of statistical methods used in molecular marker studies in cancer. Cancer,2008,112: 1862-1868.
